Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06880809

Bridge the Gap (BTG) - Black Youth Group

The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:

-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.

Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.

Recruiting

Interested in participating?

Request Info

Key information

Age range

12 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

Location status: Recruiting

Location contact

Tia Tyndal, Ph.D.

CONTACT

[email protected]

323-361-4648

Tia Tyndal, Ph.D.

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 12-17 years old
  • Identify as Black or African American or being of African descent
  • Have current suicidal ideation or suicidal ideation within the last 30 days
  • Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.

Exclusion criteria

  • An active psychotic disorder or current psychosis symptoms
  • No history of suicide attempt(s) or suicide ideation in the past 30 days
  • Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF & SSP
  • Caregivers, guardians, and/or the patient refuse to participate.

Treatment and study plan

Bridge the Gap (BTG) - Black Youth Group

Behavioral

Participants will complete a group intervention, rooted in the Collaborative Assessment & Management of Suicidality (CAMS) evidence-based model, driven by their own unique identification of suicide drivers.

Primary outcomes

  1. The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)

    Time frame: From pre-treatment until 3 months post-treatment, approximately 23 weeks.

    An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.

  2. Ethnic Identity Scale (EIS)

    Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.

    A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.

  3. Living Ladder Scale

    Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.

    A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.

  4. Brief Suicide Cognitions Scale (B-SCS)

    Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.

    A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.

  5. Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR)

    Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.

    A 12-item scale that reflects Bordin's three-dimensional conceptualization of therapeutic alliance: task, goal, and bond. Scores range from 12-60, with higher scores indicating higher therapeutic alliance.

  6. Optimism and Hope Scale (OHS)

    Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.

    A 14-item scale that measures an individual's level of both optimism, as characterized by a positive outlook on the future, and hope, as characterized by the belief in one's ability to achieve goals and navigate challenges. Scores range from 14-56, with lower scores indicating more hope and optimism.

  7. Parent Readiness for Hospital Discharge Scale (RHDS)

    Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.

    A 23-item scale aimed at providing a discharge readiness assessment before pediatric discharge from care in hospital settings. Scores range from 0-80, with higher scores indicating more readiness.

  8. Group Cohesion Scale

    Time frame: From baseline until the beginning of post-treatment, approximately 10 weeks.

    A 12-item self-report scale that measures group cohesion, including dimensions of engagement, conflict, and avoidance. Scores across the subscales range from 0-72; higher scores indicate more of that dimension.

Study contacts

Contact information is provided by the study sponsor or research team.

Amy West, PhD

CONTACT

[email protected]

323-361-4478

Tia Tyndal, PhD

CONTACT

[email protected]

323-361-4648

Sponsors and collaborators

Lead sponsor

Children's Hospital Los Angeles

Other

Collaborators

  • American Psychological Foundation

Registry information

Official study title

Bridging the Gap: A Collaborative Intervention Group for Black Youth at Risk for Suicide

Acronym: Bridge the Gap

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Mar 18, 2025
Registry last updated
Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.